Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

FB 04 - Universitätsmedizin

Johannes Gutenberg-Universität Mainz

Obere Zahlbacher Str. 63, Geb. 912, 55131 Mainz
  • 06131/17-9704 oder 9799 (Sekretariat)
  • 06131/17-9669
Publikationen
Ergebnisse pro Seite:  10

Klok, Frederikus A.; Sharp, Andrew; Ahrens, Ingo et al.

Rationale for and approach to establishing a multidisciplinary acute pulmonary embolism expert care team

EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE. 2025


Stenzel, P. J.; Tagscherer, K. E.; Justenhoven, C. et al.

RCC-Ma loss predicts poor survival and metastatic risk in clear cell renal cell carcinoma

PATHOLOGY RESEARCH AND PRACTICE. Bd. 269. 2025


Haack, Maximilian; Neuberger, Stephanie; Boerner, Jan Hendrik et al.

Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinoma

DISCOVER ONCOLOGY. Bd. 16. H. 1. 2025



Wolfrum, Peter; Voigt, Anna Maria; Lorenz, Katrin et al.

Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. 2025 S. 7


Meyer, Anna C.; Wick, Moritz; Damm, Oliver et al.

Real-world evidence on the prophylaxis of respiratory syncytial virus diseases in infants with nirsevimab

MONATSSCHRIFT KINDERHEILKUNDE. 2025


Wegner, Joanna; Gross, Karolin; Ghoreishi, Yalda et al.

Real-world evidence-biosimilars can successfully substitute biologics in psoriasis and hidradenitis suppurativa

POSTEPY DERMATOLOGII I ALERGOLOGII. Bd. 42. H. 5. 2025 S. 488-493


Rautenberg, Christina; Middeke, Jan Moritz; Roellig, Christoph et al.

Real-world experience with first-line CPX-351 treatment in patients with acute myeloid leukemia - long-term follow-up with focus on younger patients

BLOOD CANCER JOURNAL. Bd. 15. H. 1. 2025



Dietz, Julia; Graf, Christiana; Boettler, Tobias et al.

Real-world outcomes in patients with Voxilaprevir (VOX)/ Velpatasvir (VEL)/Sofosbuvir (SOF) treatment failure: a follow-up study

JOURNAL OF HEPATOLOGY. Bd. 82. 2025